Kerala Ayurveda Ltd — Board Meeting, 12-02-2026: Board Meeting

Kerala Ayurveda's Board approved Q3 results, reporting a consolidated loss of ₹4.60 Cr. Key decisions include a ₹20.66 Cr preferential share issue to convert a promoter loan and acquiring the remaining 26% of Ayurvedagram for ₹10.00 Cr via a share swap. An EGM is set for March 14.